Quantinno Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Quantinno Capital Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,305	Closed	-$103K	–	2975
2025 Q2	$103K	Buy	+10,305	New	+$83K	﹤0.01%	2509

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quantinno Capital Management's ITOS Position: Q3 2025 in Review

Quantinno Capital Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 10,305 shares — an estimated $103K sold.

Quantinno Capital Management first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $103K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Quantinno Capital Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Quantinno Capital Management sold 10,305 iTeos Therapeutics shares in Q3 2025, an estimated $103K.
Quantinno Capital Management first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
Quantinno Capital Management's iTeos Therapeutics position peaked at $103K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Quantinno Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.